Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Blood Purification|July 5, 2018
Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive ModelsThomas Jouve, Raphaël Marlu, Paolo Malvezzi, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 9, 2013
Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still's diseasePierre-Louis Carron, Jean-Charles Cartier, Anne-Sophie Truche, et al.
The American Journal of Surgical Pathology|May 27, 2003
The Ron proto-oncogene product is a phenotypic marker of renal oncocytomaTeresa Rampino, Marilena Gregorini, Grazia Soccio, et al.
Frontiers in Immunology|April 18, 2022
Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm StudyThomas Jouve, Johan Noble, Hamza Naciri-Bennani, et al.
Transplantation|August 16, 2019
The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-censored Graft SurvivalThomas Jouve, Xavier Fonrose, Johan Noble, et al.
Clinical Biochemistry|October 23, 2020
Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kitsAurélie Truffot, Jean-François Jourdil, Barbara Seitz-Polski, et al.
Nephrologie & Therapeutique|October 6, 2019
[How to implement a complete apheresis program within a hemodialysis unit]Jocelyne Maurizi-Balzan, Thomas Jouve, Hamza Naciri-Bennani, et al.
Journal of Clinical Medicine|January 21, 2023
Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA StudyThomas Jouve, Mélanie Daligault, Johan Noble, et al.
Kidney International Reports|June 20, 2024
Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to BelataceptLara Cabezas, Aurelie Truffot, Raphaele Germi, et al.
Case Reports in Nephrology and Dialysis|March 12, 2021
A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and InfectionQuentin Perrier, Antoine Portais, Florian Terrec, et al.
Pageof 12